Vanguard Trims FibroGen Stake to 5.2%, Holding 4.97M Shares

TL;DR

**Vanguard cut its FibroGen stake to 5.2%, signaling a potential bearish shift.**

AI Summary

The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in FibroGen Inc. As of December 29, 2023, Vanguard beneficially owned 4,967,362 shares of FibroGen's Common Stock, representing 5.2% of the company. This is a decrease from their previous filing, indicating Vanguard has reduced its stake, which could signal a less bullish outlook on FibroGen's future performance.

Why It Matters

This filing shows that a major institutional investor, Vanguard, has reduced its ownership in FibroGen, which might suggest a shift in their investment strategy or outlook on the company's prospects.

Risk Assessment

Risk Level: medium — A large institutional investor reducing its stake can indicate concerns about the company's future, potentially leading to downward pressure on the stock price.

Analyst Insight

A smart investor would investigate the reasons behind Vanguard's reduction in FibroGen shares and consider if this signals underlying issues with the company's fundamentals or future prospects before making any investment decisions.

Key Numbers

• 4,967,362 — Shares Beneficially Owned (The total number of FibroGen shares Vanguard holds, indicating their significant, though reduced, investment.)
• 5.2% — Percentage of Class Outstanding (This percentage shows Vanguard's current influence and stake in FibroGen, a decrease from previous filings.)
• 42,258 — Shared Voting Power (The number of shares Vanguard can vote on jointly with others, indicating a small portion of their total holding.)
• 4,925,104 — Shared Dispositive Power (The number of shares Vanguard can decide to sell jointly with others, representing the majority of their holding.)

Key Players & Entities

• The Vanguard Group (company) — reporting person, institutional investor
• FibroGen Inc (company) — subject company, pharmaceutical preparations
• 4,967,362 shares (dollar_amount) — total shares beneficially owned by Vanguard
• 5.2% (dollar_amount) — percentage of class outstanding owned by Vanguard
• December 29, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• FibroGen's stock price may experience downward pressure due to Vanguard's reduced stake. (FibroGen Inc) — medium confidence, target: Q1 2024
• Other institutional investors might re-evaluate their positions in FibroGen following Vanguard's move. (Institutional Investors) — low confidence, target: Q2 2024

FAQ

Filing Documents

• tv0921-fibrogeninc.htm (SC 13G/A) — 11KB
• 0001104659-24-020921.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: FibroGen Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 409 Illinois Street San Francisco, CA 94158-2509

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 31572Q808

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR